Art

J-GLOBAL ID：201202231149342000   Reference number：12A1050285

Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor

アンギオテンシン変換酵素抑制薬を受けた急性心筋梗塞患者に伴う冠状動脈硬化症に対するバルサルタン,アンギオテンシンII受容体拮抗薬の効果

Author (12)： YANO Hideto (Div. of Cardiology, Yokohama City Univ. Medical Center) ,  HIBI Kiyoshi (Div. of Cardiology, Yokohama City Univ. Medical Center) ,  NOZAWA Naoki (Div. of Cardiology, Yokohama City Univ. Medical Center) ,  OZAKI Hiroyuki (Div. of Cardiology, Yokohama City Univ. Medical Center) ,  KUSAMA Ikuyoshi (Div. of Cardiology, Yokohama City Univ. Medical Center) ,  EBINA Toshiaki (Div. of Cardiology, Yokohama City Univ. Medical Center) ,  KOSUGE Masami (Div. of Cardiology, Yokohama City Univ. Medical Center) ,  TSUKAHARA Kengo (Div. of Cardiology, Yokohama City Univ. Medical Center) ,  OKUDA Jun (Div. of Cardiology, Yokohama City Univ. Medical Center) ,  MORITA Satoshi (Dep. of Biostastics and Epidemiology, Yokohama City Univ. Medical Center) ,  UMEMURA Satoshi (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine) ,  KIMURA Kazuo (Div. of Cardiology, Yokohama City Univ. Medical Center)
Material： Circulation Journal  (Circ J)
Volume： 76  Issue： 6  Page： 1442-1451 (J-STAGE)  Publication year： 2012 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *angiotensin converting enzyme inhibitor ,...
Semi thesaurus term： *coronary arteriosclerosis ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A1050285&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (2)： Clinical application of vasoactive drugs and hypotensive drugs  (GW07050U) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (2)： Valsartan ,  Captopril

Reference (25)：

• PFEFFER, MA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction : Results of the survival and ventricular enlargement trial : The SAVE Investigators. N Engl J Med. 1992, 327, 669-677
• YUSUF, S. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients : The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000, 342, 145-153
• PFEFFER, MA. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003, 349, 1893-1906
• YUSUF, S. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008, 358, 1547-1559
• MCMURRAY, JJ. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors : The CHARM-Added trial. Lancet. 2003, 362, 767-771

Terms in the title (6)： アンギオテンシン変換酵素 ,  急性心筋梗塞 ,  患者 ,  冠状動脈硬化症 ,  バルサルタン ,  アンギオテンシンII受容体拮抗薬